9-35060305-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_007126.5(VCP):​c.1695+8A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.654 in 1,613,318 control chromosomes in the GnomAD database, including 362,752 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 26017 hom., cov: 33)
Exomes 𝑓: 0.67 ( 336735 hom. )

Consequence

VCP
NM_007126.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00003988
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 0.129

Publications

27 publications found
Variant links:
Genes affected
VCP (HGNC:12666): (valosin containing protein) This gene encodes a member of the AAA ATPase family of proteins. The encoded protein plays a role in protein degradation, intracellular membrane fusion, DNA repair and replication, regulation of the cell cycle, and activation of the NF-kappa B pathway. This protein forms a homohexameric complex that interacts with a variety of cofactors and extracts ubiquitinated proteins from lipid membranes or protein complexes. Mutations in this gene cause IBMPFD (inclusion body myopathy with paget disease of bone and frontotemporal dementia), ALS (amyotrophic lateral sclerosis) and Charcot-Marie-Tooth disease in human patients. [provided by RefSeq, Aug 2017]
VCP Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • inclusion body myopathy with Paget disease of bone and frontotemporal dementia
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Charcot-Marie-Tooth disease type 2Y
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 6
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • adult-onset distal myopathy due to VCP mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • frontotemporal dementia with motor neuron disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • spastic paraplegia-Paget disease of bone syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 9-35060305-T-C is Benign according to our data. Variant chr9-35060305-T-C is described in ClinVar as Benign. ClinVar VariationId is 260124.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.703 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VCPNM_007126.5 linkc.1695+8A>G splice_region_variant, intron_variant Intron 13 of 16 ENST00000358901.11 NP_009057.1
VCPNM_001354927.2 linkc.1560+8A>G splice_region_variant, intron_variant Intron 13 of 16 NP_001341856.1
VCPNM_001354928.2 linkc.1560+8A>G splice_region_variant, intron_variant Intron 13 of 16 NP_001341857.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VCPENST00000358901.11 linkc.1695+8A>G splice_region_variant, intron_variant Intron 13 of 16 1 NM_007126.5 ENSP00000351777.6

Frequencies

GnomAD3 genomes
AF:
0.546
AC:
83057
AN:
152050
Hom.:
26006
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.273
Gnomad AMI
AF:
0.689
Gnomad AMR
AF:
0.659
Gnomad ASJ
AF:
0.664
Gnomad EAS
AF:
0.0838
Gnomad SAS
AF:
0.481
Gnomad FIN
AF:
0.606
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.709
Gnomad OTH
AF:
0.587
GnomAD2 exomes
AF:
0.592
AC:
148418
AN:
250840
AF XY:
0.596
show subpopulations
Gnomad AFR exome
AF:
0.265
Gnomad AMR exome
AF:
0.666
Gnomad ASJ exome
AF:
0.668
Gnomad EAS exome
AF:
0.0848
Gnomad FIN exome
AF:
0.610
Gnomad NFE exome
AF:
0.709
Gnomad OTH exome
AF:
0.640
GnomAD4 exome
AF:
0.665
AC:
971828
AN:
1461150
Hom.:
336735
Cov.:
44
AF XY:
0.662
AC XY:
480937
AN XY:
726920
show subpopulations
African (AFR)
AF:
0.255
AC:
8543
AN:
33462
American (AMR)
AF:
0.666
AC:
29756
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.663
AC:
17328
AN:
26130
East Asian (EAS)
AF:
0.0688
AC:
2730
AN:
39696
South Asian (SAS)
AF:
0.505
AC:
43507
AN:
86234
European-Finnish (FIN)
AF:
0.607
AC:
32420
AN:
53402
Middle Eastern (MID)
AF:
0.598
AC:
3446
AN:
5764
European-Non Finnish (NFE)
AF:
0.717
AC:
796587
AN:
1111408
Other (OTH)
AF:
0.621
AC:
37511
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
16868
33736
50605
67473
84341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19472
38944
58416
77888
97360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.546
AC:
83100
AN:
152168
Hom.:
26017
Cov.:
33
AF XY:
0.540
AC XY:
40184
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.273
AC:
11332
AN:
41528
American (AMR)
AF:
0.659
AC:
10077
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.664
AC:
2303
AN:
3470
East Asian (EAS)
AF:
0.0839
AC:
435
AN:
5182
South Asian (SAS)
AF:
0.481
AC:
2319
AN:
4818
European-Finnish (FIN)
AF:
0.606
AC:
6407
AN:
10568
Middle Eastern (MID)
AF:
0.616
AC:
181
AN:
294
European-Non Finnish (NFE)
AF:
0.709
AC:
48181
AN:
67986
Other (OTH)
AF:
0.585
AC:
1237
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1637
3275
4912
6550
8187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
684
1368
2052
2736
3420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.651
Hom.:
21283
Bravo
AF:
0.536
Asia WGS
AF:
0.303
AC:
1059
AN:
3478
EpiCase
AF:
0.703
EpiControl
AF:
0.703

ClinVar

Significance: Benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29851785) -

Jul 21, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;C5436279:Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 2Y Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
7.2
DANN
Benign
0.82
PhyloP100
0.13
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000040
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs684562; hg19: chr9-35060302; COSMIC: COSV62720360; COSMIC: COSV62720360; API